Breaking News, Collaborations & Alliances

Lonza Enters Collaborations with McSAF and Cristal Therapeutics

Aims to expand its bioconjugates offering.

Author Image

By: Charlie Sternberg

Associate Editor

Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced new collaborations with McSAF and Cristal Therapeutics to expand its bioconjugates offering.   The collaborations will enable the integration of two novel conjugation platforms, McSAF Inside and CliCr, into the Lonza Bioconjugation Toolbox. The Lonza Bioconjugation Toolbox comprises a range of tailored solutions for the technology selection, development and manufacturing of bioconjugates to adv...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters